Survey on immunotherapy practice patterns: Dose, dose adjustments, and duration

Annals of Allergy, Asthma and Immunology

Volumn 108, Issue 5, 2012, Pages 373-378.e3

  Larenas Linnemann, Désirée E S ^a   Gupta, Payel ^b   Mithani, Sima ^c   Ponda, Punita ^c  

^a LIVER RESEARCH UNIT   (Mexico)

^b LONG ISLAND COLLEGE HOSPITAL   (United States)

^c LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN;

ALLERGEN IMMUNOTHERAPY; ALLERGIST; CANADA; CLINICAL PRACTICE; HEALTH SURVEY; HUMAN; IMMUNOTHERAPY; MEDICAL SOCIETY; OPTIMAL DRUG DOSE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; TREATMENT DURATION; UNITED STATES;

EID: 84860366561     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2012.03.009     Document Type: Article

References (32)

1. L. Noon Prophylactic inoculation against hay fever Lancet 1 1911 1572 1573
2. E. Alvarez-Cuesta, J. Bousquet, G.W. Canonica, S.R. Durham, H.J. Malling, E. Valovirta Standards for practical allergen-specific immunotherapy Allergy 61 suppl 82 2006 1 20
3. E. Leith, T. Bowen, J. Butchey Consensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI) Allergy Asthma Clin Immunol 2 2006 47 61
4. L. Cox, H. Nelson, R. Lockey Allergen immunotherapy: A Practice Parameter Third Update J Allergy Clin Immunol 127 1 suppl 2011 S1 S55
5. D. Larenas-Linnemann, J.A. Ortega-Martell, B. Del Rio-Navarro Mexican clinical practice guidelines of immunotherapy 2011 [in Spanish] Rev Alerg Mex 58 2011 3 75
6. S.M. Walker, S.R. Durham, S.J. Till Immunotherapy for allergic rhinitis Clin Exp Allergy 41 2011 1177 1200
7. T. Chacko Are we following practice parameter guidelines on allergen immunotherapy? Ann Allergy Asthma Immunol 100 2008 178
8. H.S. Nelson The use of standardized extracts in allergen immunotherapy J Allergy Clin Immunol 106 1 pt 1 2000 41 45
9. J.R. Montgomery The need for standardizing the aeroallergen immunotherapy missed-dose adjustment protocol Allergy Asthma Proc 29 2008 425 426
10. L. Cox, J.R. Cohn Duration of allergen immunotherapy in respiratory allergy: when is enough, enough? Ann Allergy Asthma Immunol 98 2007 416 426
11. S.R. Durham, S.M. Walker, E.M. Varga Long-term clinical efficacy of grass-pollen immunotherapy N Engl J Med 341 1999 468 475
12. L. Jacobsen, B. Niggemann, S. Dreborg Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study Allergy 62 2007 943 948
13. P.A. Eng, M. Borer-Reinhold, I.A. Heijnen, H.P. Gnehm Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood Allergy 61 2006 198 201
14. A.I. Tabar, E. Arroabarren, S. Echechipia, B.E. Garcia, S. Martin, M.J. Alvarez-Puebla Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy J Allergy Clin Immunol 127 2011 57 63 e1-3
15. A. Des Roches, L. Paradis, J. Knani Immunotherapy with a standardized Dermatophagoides pteronyssinus extract, V: duration of the efficacy of immunotherapy after its cessation Allergy 51 1996 430 433
16. G. Hedlin, H. Heilborn, G. Lilja Long-term follow-up of patients treated with a three-year course of cat or dog immunotherapy J Allergy Clin Immunol 96 6 pt 1 1995 879 885
17. C. Ebner, D. Kraft, H. Ebner Booster immunotherapy (BIT) Allergy 49 1994 38 42
18. Allergen Immunotherapy: A Practice Parameter Second Update J Allergy Clin Immunol 120 3 suppl 2007 S25 S85
19. R.E. Coifman, L.S. Cox 2006 American Academy of Allergy, Asthma & Immunology member immunotherapy practice patterns and concerns J Allergy Clin Immunol 119 2007 1012 1013
20. B.D. Robertson, R.L. McCoy, M.R. Nelson, B.R. Haymore Effect of allergen immunotherapy practice parameters on cat extract prescribing patterns, 1993-2009 Ann Allergy Asthma Immunol 107 2011 437 440
21. American Academy of Allergy, Asthma and Immunology and American College of Allergy, Asthma and Immunology Allergen Immunotherapy: A Practice Parameter Ann Allergy Asthma Immunol. 90 1 suppl 1 2003 1 40
22. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology Practice Parameters for Allergen Immunotherapy J Allergy Clin Immunol 98 6 pt 1 1996 1001 1011
23. S. Dain Normal accidents: human error and medical equipment design Heart Surg Forum 5 2002 254 257
24. C.M. Webber, C.W. Calabria Assessing the safety of subcutaneous immunotherapy dose adjustments Ann Allergy Asthma Immunol 105 2010 369 375
25. P.R. Hunter, K. Bickerstaff, M.A. Davies Potential sources of bias in the use of individual's recall of the frequency of exposure to air pollution for use in exposure assessment in epidemiological studies: a cross-sectional survey Environ Health 3 2004 3
26. M. Kulig, R. Bergmann, G. Edenharter, U. Wahn Multicenter Allergy Study Group Does allergy in parents depend on allergy in their children? recall bias in parental questioning of atopic diseases J Allergy Clin Immunol 105 2 pt 1 2000 274 278
27. C.S. Hankin, L. Cox, D. Lang Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs J Allergy Clin Immunol 121 2008 227 232
28. P.J. Gergen, P.C. Turkeltaub The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976-80 (NHANES II) J Allergy Clin Immunol 90 4 pt 1 1992 579 588
29. P.J. Bousquet, S. Chinn, C. Janson, M. Kogevinas, P. Burney, D. Jarvis Geographical variation in the prevalence of positive skin tests to environmental aeroallergens in the European Community Respiratory Health Survey I Allergy 62 2007 301 309
30. R. Dahl, A. Kapp, G. Colombo Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis J Allergy Clin Immunol 118 2006 434 440
31. R. Dahl, A. Stender, S. Rak Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis Allergy 61 2006 185 190
32. D. Larenas-Linnemann, R. Esch, G. Plunkett Maintenance dosing for sublingual immunotherapy by prominent European allergen manufacturers expressed in bioequivalent allergy units Ann Allergy Asthma Immunol 107 2011 448 458, e3